Related Experiment Video
Updated: Jun 26, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas
Tania C Araujo-Jorge1, Maria Teresa Rivera2, Jean Vanderpas2
1Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Avenida Brasil 4365, Manguinhos, Pavilhão Cardoso Fontes, Sala 64, Rio de Janeiro 21040-360, Brazil.
Selenium (Se) may help prevent heart failure in chronic Chagas disease cardiomyopathy (CCC). Studies suggest Se deficiency is linked to heart inflammation and that Se could be a complementary therapy for CCC patients.
Area of Science:
- Cardiovascular Medicine
- Parasitology
- Nutritional Science
Background:
- Chronic Chagas disease cardiomyopathy (CCC) is a significant global health issue, particularly in Latin America.
- Selenium (Se) is an essential micronutrient known for its role in cardiovascular homeostasis.
- The link between Se deficiency and CCC's cardiac inflammation and arrhythmogenesis requires further investigation.
Purpose of the Study:
- To review recent research on selenium's role in chronic Chagas disease cardiomyopathy (CCC).
- To explore whether selenium deficiency contributes to heart inflammation and arrhythmias in CCC.
- To assess the potential of selenium as a complementary therapeutic strategy for CCC.
Main Methods:
- Review of experimental and clinical studies from the past 20 years on CCC and selenium.
- Analysis of the interplay between CCC pathophysiology, transforming growth factor-beta (TGF-β), and immune response.
- Evaluation of selenoproteins' antioxidant functions in inflammatory environments.
Main Results:
- Evidence suggests a relationship between Se deficiency and heart inflammation/arrhythmogenesis in CCC.
- Transforming growth factor-beta (TGF-β) pathways are implicated in CCC fibrosis.
- Selenoproteins may act as antioxidants, mitigating oxidative stress in CCC.
Conclusions:
- Selenium may serve as a complementary therapy to prevent heart failure in CCC patients.
- Modulating TGF-β pathways and utilizing selenoproteins are potential strategies for managing CCC.
- Further research is warranted to confirm selenium's beneficial effects in CCC management.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Leishmaniasis
Toxoplasmosis
American Trypanosomiasis
Antiprotozoal Agents

